Weight-Loss Drug Wars Escalate: Novo Nordisk Sues Hims & Hers Over Compounded Semaglutide
The Weight-Loss Revolution: Telehealth Giant Hims & Hers Dives into the GLP-1 Market
The Silent Threat: A Mother's Fight for Answers After a Compounded Drug Claims Her Son's Life
The Wild West of Weight Loss: Unpacking the Perils of Online Compounded GLP-1s